Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.
- Revenue
- +4.29%
- EPS
- +2.17%
- Free cash flow
- +27.0%
- Total debt
- −18.1%
Quarter to September 2026, against a year earlier
Follow RVTY
Alert me
Revvity Inc. (RVTY) Gross margin
Revvity Inc.'s gross margin over the twelve months to 30 September 2026 was 55.9%, up 1.1 percentage points from fiscal 2025 (54.8%). Over the past ten years it has ranged from 45.8% (fiscal 2015) to 65.0% (fiscal 2020); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 48.3% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 54.8% | (1.04) |
| FY2024 | 55.8% | (0.17) |
| FY2023 | 56.0% | (4.10) |
| FY2022 | 60.1% | (3.51) |
| FY2021 | 63.6% | (1.38) |
| FY2020 | 65.0% | 16.56 |
| FY2019 | 48.4% | 0.14 |
| FY2018 | 48.3% | 0.70 |
| FY2017 | 47.6% | (0.38) |
| FY2016 | 48.0% | 2.14 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 57.4% | 0.30 |
| Jun 2026 | 57.1% | 2.62 |
| Mar 2026 | 54.5% | (0.11) |
| Dec 2025 | 54.6% | 1.02 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.2% |
| ILMN Illumina, Inc. compare | 67.9% |
| GH Guardant Health, Inc. compare | 65.2% |
| QGEN QIAGEN N.V. compare | 62.2% |
| RVTY Revvity Inc. | 55.9% |
| CRL Charles River Laboratories International, Inc. compare | 33.3% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| ICLR ICON PLC compare | 23.4% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on RVTY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement